mitoxantrone has been researched along with Depression in 5 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone (MX) is a potent immunosuppressant that is licensed as escalation therapy for the treatment of active multiple sclerosis (MS)." | 1.37 | Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: a pilot analysis. ( Gold, R; Klotz, P; Lee, DH; Linker, RA; Schröder, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dresler, M | 1 |
| Genzel, L | 1 |
| Kluge, M | 1 |
| Schüssler, P | 1 |
| Weber, F | 1 |
| Rosenhagen, M | 1 |
| Steiger, A | 1 |
| Schröder, A | 1 |
| Klotz, P | 1 |
| Lee, DH | 1 |
| Gold, R | 1 |
| Linker, RA | 1 |
| Aguila, B | 1 |
| Coulbault, L | 1 |
| Boulouard, M | 1 |
| Léveillé, F | 1 |
| Davis, A | 1 |
| Tóth, G | 1 |
| Borsodi, A | 1 |
| Balboni, G | 1 |
| Salvadori, S | 1 |
| Jauzac, P | 1 |
| Allouche, S | 1 |
| Zéphir, H | 1 |
| de Sèze, J | 1 |
| Dujardin, K | 1 |
| Dubois, G | 1 |
| Cabaret, M | 1 |
| Bouillaguet, S | 1 |
| Ferriby, D | 1 |
| Stojkovic, T | 1 |
| Vermersch, P | 1 |
| Carlson, LE | 1 |
| Koski, T | 1 |
| Glück, S | 1 |
2 trials available for mitoxantrone and Depression
| Article | Year |
|---|---|
Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression.
Topics: Adrenal Cortex Hormones; Adult; Aged; Depression; Dose-Response Relationship, Drug; Female; Humans; | 2010 |
[Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study].
Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cognition Disorders; Depression; Disease Progression; F | 2008 |
3 other studies available for mitoxantrone and Depression
| Article | Year |
|---|---|
Stability of cognitive functions under mitoxantrone therapy in patients with progressive multiple sclerosis: a pilot analysis.
Topics: Adult; Cognition; Depression; Executive Function; Female; Follow-Up Studies; Humans; Immunosuppressi | 2011 |
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bind | 2007 |
Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Arthralgia; Bone Neoplas | 2001 |